Dr. Sanchari Sinha Dutta

Feature Writer

B.Sc. Physiology, M.Sc. Physiology, Ph.D. Physiology

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world.

Since she was very young, Dr. Dutta was passionate about the world of science and making it accessible to all. During her time at school, Dr. Dutta particularly enjoyed taking part in biology experiments in the laboratory. The inner workings and diversity of the human body used to surprise her every day and eventually inspired her to become a biologist.

In order to learn more about the subject, Sanchari decided to take biology as her main subject at university and gained Bachelor of Science (B.Sc.) and Master of Science (M.Sc.) degrees in human physiology from the University of Calcutta, India.

This was followed by a Ph.D., also in physiology. During her tenure (2004 – 2010), she received the ‘Surg. Rear Admiral M.S. Malhotra Research Prize’ for best publication from the Defence Institute of Physiology and Allied Sciences, India.

Her thirst for knowledge and dream to be a science writer were always abreast throughout her academic tenure. However, instead of starting her career as a writer straight away, Sanchari decided to further her knowledge of the molecular biology of the human body and carried out postdoctoral research for 6 years after her Ph.D.

During this period, Dr. Dutta received ‘Dean of Faculty fellowship of Weizmann Institute of Science, Israel’ and ‘PBC fellowship for outstanding post-doctoral researchers from China and India in Israeli universities’.

Alongside bench work, she authored more than 10 original research articles, all published in renowned international journals.

In 2016, she started working with a leading medical communication company and formally became a freelance science writer. Since then, she has engaged in writing a wide variety of scientific articles, including original research articles, review articles, science discoveries, popular science articles, and healthcare articles. Her first review article as a science writer was recently published in the journal ‘Oxidative Medicine and Cellular Longevity’.

Her work with News Medical offers a great platform for a wide range of audience to learn about the science behind good health.

See less

Articles from Sanchari Sinha Dutta

Myocarditis risk from mRNA COVID vaccines re-evaluated in Canadian study (Research Now Withdrawn)

Scientists from the University of Ottawa, Canada, have recently estimated the prevalence of myocarditis/pericarditis in individuals recently immunized with mRNA-based coronavirus disease 2019 (COVID-19) vaccines. The analysis reveals a prevalence of 10 myopericarditis cases for every 10,000 vaccine doses. The study is currently available on the medRxiv* preprint server.

20 Sep 2021

What pushed Israel out of herd immunity?

Scientists have recently tried to explain the factors that could be responsible for the recent outbreaks of COVID-19 in Israel.

17 Sep 2021

Natural SARS-CoV-2 infection induces more durable immunity than vaccination study suggests

Scientists from the USA have demonstrated that immunity induced by mRNA-based COVID-19 vaccines in previously SARS-CoV-2-infected people has the highest robustness and durability with cross-reactivity against different viral variants.

15 Sep 2021

Vaccination of children before school reopening may control COVID-19 pandemic

A team has recently explored the impact of non-pharmaceutical control measures and vaccination on the COVID-19 pandemic during school reopening in England.

15 Sep 2021

Lessons from COVID-19 response during first three waves in New South Wales

Scientists from Australia have recently analyzed the public health measures adopted by the authorities during the three waves of coronavirus disease 2019 (COVID-19) pandemic in New South Wales, Australia.

12 Sep 2021

Scientists develop a novel and potent SARS-CoV-2 RBD-homodimer vaccine

A recent report published in the journal Cell Discovery has described the immunogenicity and protective efficacy of a novel coronavirus disease 2019 (COVID-19) subunit vaccine candidate. The vaccine induces robust immune responses in rodents and non-human primates and protects the animals against severe disease.

12 Sep 2021

School children in Switzerland show willingness to mask-wearing

A school-based survey has revealed that about 60% of students in Zurich perceive mask-wearing at school as a useful intervention for controlling SARS-CoV-2 transmission.

10 Sep 2021

SARS-CoV-2 transmission dynamics in Nordic countries

Scientists have recently assessed the strategies adopted by the Nordic countries to curb the trajectory of the COVID-19 pandemic.

10 Sep 2021

Immunity induced by Pfizer/BioNTech COVID-19 vaccine declines with time, Mayo Clinic study finds

In a study conducted at the Mayo Clinic, USA, scientists have investigated the long-term efficacy of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 (Pfizer/BioNTech) against symptomatic disease.

8 Sep 2021

Severe COVID-19 is associated with expansion of immature myeloid cells and inflammation

A team of scientists in Ireland recently identified certain immune markers that can predict the progression of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to severe coronavirus disease 2019 (COVID-19). Early detection of these predictive markers can facilitate therapeutic decision-making prior to peak severity.

7 Sep 2021